Supplementary Material for: Management of Older Outpatients during the COVID-19 Pandemic: The GeroCovid Ambulatory Study

<b><i>Objectives:</i></b> The GeroCovid Study is a multi-setting, multinational, and multi-scope registry that includes the GeroCovid home and outpatients’ care cohort. The present study aims to evaluate whether outpatient and home care services with remote monitoring and consultation could mitigate the impact of the COVID-19 pandemic on mental and affective status, perceived well-being, and personal capabilities of outpatients and home care patients with cognitive disorders. <b><i>Methods:</i></b> Prospectively recorded patients in an electronic web registry provided by BlueCompanion Ltd. Up to October 31, 2020, the sample included 90 patients receiving regular care from the Center for Cognitive Disorders and Dementia in Catanzaro Lido, Italy. It was made of 52 ambulatory outpatients and 38 home care patients, mean age 83.3 ± 7.54 years. Participants underwent a multidimensional assessment at baseline (T0) and after 90 days (T1). For each patient, we administered the Mini-Mental State Examination (MMSE) for cognitive functions, the Activities of Daily Living (ADL) and Instrumental ADL (IADL) scales for functional capabilities, the Cumulative Illness Rating Scale (CIRS) for comorbidities and their impact on patients’ health, the 5-items Geriatric Depression Scale (GDS) for mood, and the Euro Quality of Life (EuroQoL) for perceived quality of life. Contacts with both ambulatory and home care patients were managed in person or via telephone, preferably through video calls (WhatsApp or FaceTime). <b><i>Results:</i></b> Contacts with patients were kept at T0 through telephone. At T1, visits were made in person for over 95% out of the cases. The ADL, IADL, CIRS, GDS, MMSE, and EuroQoL changed slightly between T0 and T1. Most of the patients were clinically stable over time on the majority of the scales explored, but behavioral changes were found in 24.4% of patients and anxiety and insomnia in 17.7% of patients. <b><i>Conclusion:</i></b> Our study suggests that contacts through telephone and video consultations are likely associated with a health status preservation of the patients.

<b><i>研究目的：</i></b> GeroCovid研究（GeroCovid Study）是一项多场景、跨国、多维度的登记研究库，涵盖GeroCovid居家与门诊护理队列。本研究旨在评估搭载远程监测与咨询服务的门诊及居家护理方案，能否缓解新冠疫情对认知障碍门诊及居家护理患者的精神情感状态、主观幸福感与个人功能的负面影响。<b><i>研究方法：</i></b> 研究对象为BlueCompanion有限公司（BlueCompanion Ltd.）搭建的电子网络登记库中前瞻性收录的患者。截至2020年10月31日，样本共纳入90名来自意大利卡坦扎罗里多认知障碍与痴呆中心接受常规护理的患者，其中门诊患者52例，居家护理患者38例，平均年龄为83.3±7.54岁。所有受试者分别在基线期（T0）与90天后（T1）接受多维评估：针对认知功能，采用简易精神状态检查表（Mini-Mental State Examination, MMSE）；针对功能能力，采用日常生活活动能力量表（Activities of Daily Living, ADL）与工具性日常生活活动能力量表（Instrumental ADL, IADL）；针对共病及其对患者健康的影响，采用累积疾病评定量表（Cumulative Illness Rating Scale, CIRS）；针对情绪状态，采用5条目老年抑郁量表（5-items Geriatric Depression Scale, GDS）；针对主观生命质量，采用欧洲生命质量量表（Euro Quality of Life, EuroQoL）。对门诊及居家护理患者的随访可采用线下访视、电话沟通形式，优先选用视频通话（WhatsApp或FaceTime）。<b><i>研究结果：</i></b> T0阶段的患者随访均通过电话完成。T1阶段中，超95%的受试者接受了线下访视。ADL、IADL、CIRS、GDS、MMSE及EuroQoL量表得分在T0与T1阶段间仅出现小幅变化。多数受试者在多数评估量表上表现为临床状态稳定，但24.4%的患者出现行为改变，17.7%的患者出现焦虑与失眠症状。<b><i>研究结论：</i></b> 本研究表明，电话与视频随访方式或可维持患者的健康状态。